These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20036559)

  • 1. Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.
    Nolan KA; Humphries MP; Barnes J; Doncaster JR; Caraher MC; Tirelli N; Bryce RA; Whitehead RC; Stratford IJ
    Bioorg Med Chem; 2010 Jan; 18(2):696-706. PubMed ID: 20036559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazoacridin-6-ones as novel inhibitors of the quinone oxidoreductase NQO2.
    Nolan KA; Humphries MP; Bryce RA; Stratford IJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2832-6. PubMed ID: 20356739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones.
    Dunstan MS; Barnes J; Humphries M; Whitehead RC; Bryce RA; Leys D; Stratford IJ; Nolan KA
    J Med Chem; 2011 Oct; 54(19):6597-611. PubMed ID: 21859103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition.
    Dufour M; Yan C; Siegel D; Colucci MA; Jenner M; Oldham NJ; Gomez J; Reigan P; Li Y; De Matteis CI; Ross D; Moody CJ
    Chembiochem; 2011 May; 12(8):1203-8. PubMed ID: 21506232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
    Nolan KA; Caraher MC; Humphries MP; Bettley HA; Bryce RA; Stratford IJ
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7331-6. PubMed ID: 21074425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents.
    Wu LQ; Ma X; Liu ZP
    Bioorg Chem; 2021 Aug; 113():104995. PubMed ID: 34034133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.
    Yan C; Dufour M; Siegel D; Reigan P; Gomez J; Shieh B; Moody CJ; Ross D
    Biochemistry; 2011 Aug; 50(31):6678-88. PubMed ID: 21718050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
    Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
    Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2).
    Hussein B; Ikhmais B; Kadirvel M; Magwaza RN; Halbert G; Bryce RA; Stratford IJ; Freeman S
    Eur J Med Chem; 2019 Nov; 182():111649. PubMed ID: 31514018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1).
    Nolan KA; Doncaster JR; Dunstan MS; Scott KA; Frenkel AD; Siegel D; Ross D; Barnes J; Levy C; Leys D; Whitehead RC; Stratford IJ; Bryce RA
    J Med Chem; 2009 Nov; 52(22):7142-56. PubMed ID: 19877692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues.
    Chen L; Xie YZ; Luo ZY; Liu LJ; Zou ZZ; Liu HD; Kong FR; Hao Y; Gao JL; Wang LL; Ma DY; Liu SY
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127286. PubMed ID: 32631508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of analogues of furan-amidines as inhibitors of NQO2.
    Alnabulsi S; Hussein B; Santina E; Alsalahat I; Kadirvel M; Magwaza RN; Bryce RA; Schwalbe CH; Baldwin AG; Russo I; Stratford IJ; Freeman S
    Bioorg Med Chem Lett; 2018 May; 28(8):1292-1297. PubMed ID: 29567345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Nad(P)H:quinone oxidoreductase (NQO1) activity mediated by 5-arylamino-2-methyl-4,7-dioxobenzothiazoles and their cytotoxic potential.
    Ryu CK; Jeong HJ; Lee SK; Kang HY; Ko KM; Sun YJ; Song EH; Hur YH; Lee CO
    Arch Pharm Res; 2000 Dec; 23(6):554-8. PubMed ID: 11156173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
    Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
    Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
    Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
    Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
    Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
    Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
    Reigan P; Colucci MA; Siegel D; Chilloux A; Moody CJ; Ross D
    Biochemistry; 2007 May; 46(20):5941-50. PubMed ID: 17455910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.